Clinical Guides
Psoriasis
A clinically focused Indian clinical guide to recognising psoriasis, using topical treatment safely and escalating through dermatology-led phototherapy or systemic care without importing an unsupervised regimen.
MedNext Academy | 14 min read
Psoriasis
A clinically focused Indian clinical guide to recognising psoriasis, using topical treatment safely and escalating through dermatology-led phototherapy or systemic care without importing an unsupervised regimen.
Summary
Psoriasis is an immune-mediated inflammatory disease of skin that commonly presents with sharply demarcated scaly plaques, but the phenotype may be plaque, guttate, flexural, scalp, nail, pustular or erythrodermic disease. It is neither infectious nor a sign of poor hygiene. Severity cannot be inferred from surface area alone: itch, pain, fissuring, sleep loss, social stigma, work, hand or foot function, genital involvement, nail disease and associated joint symptoms may make apparently limited disease clinically serious. Examination should therefore be paired with a discussion of the person’s own goals and burden.
The first task is diagnostic safety. Tinea, eczema, seborrhoeic dermatitis, pityriasis rosea, drug eruption, secondary syphilis and cutaneous T-cell lymphoma can resemble psoriasis. New fever, widespread erythema, pustules, unstable plaques, skin pain or systemic illness should not be treated as an ordinary outpatient plaque flare. Ask actively about inflammatory musculoskeletal symptoms, painful red eyes and bowel symptoms because psoriatic arthritis, uveitis and inflammatory bowel disease can alter referral and treatment choices.
For stable local disease, emollient skin care and a site-specific topical plan are central. Topical corticosteroids are useful only when their potency, vehicle, body site, frequency, maximum course and review plan are explicit. Thin or occluded skin on the face, flexures and genital area is especially vulnerable to atrophy. Phototherapy, conventional systemic therapy and biologic or targeted therapy are specialist decisions requiring phenotype confirmation, infection and reproductive-risk assessment, laboratory or other monitoring appropriate to the exact medicine, and a realistic plan for access and follow-up. This reviewed educational draft is has been reviewed by the MedNext Clinical Team; it does not authorise a patient-specific prescription or biologic initiation.
How Common Is It?
Psoriasis occurs across ages, skin tones and occupations. Published prevalence estimates vary by case definition, population sampling, access to dermatology and whether mild untreated disease is captured. A figure from another country should not be presented as a current national estimate for India. What is reliable at the clinical encounter is that psoriasis can carry substantial physical, psychological and economic burden even when it covers a small area. Scalp scale, visible plaques, palmoplantar fissures, nail change and genital disease can affect sleep, intimate relationships, education and employment out of proportion to visible extent.
The course is commonly relapsing. A quiet interval does not mean the diagnosis was wrong, and a flare does not prove that the person failed self-care. Infection, skin injury, certain medicines, smoking, alcohol excess, stress and treatment interruption can be relevant in an individual, but long trigger lists can promote blame and unhelpful restriction. The clinical aim is sustained control with the least hazardous practical treatment, not a promise of a permanent cure.
In India, the burden is shaped by travel to phototherapy centres, cost of specialist follow-up, variable availability of single-ingredient medicines, climate, work that makes frequent application difficult, and widespread availability of unlabelled or fixed-dose topical combinations. Darker skin can show less obvious erythema; scale, thickness, induration, fissuring, symptoms and change from the patient’s usual skin colour may be more informative. Post-inflammatory hyperpigmentation or hypopigmentation may persist after active inflammation has settled and is not alone a reason to intensify anti-inflammatory treatment.
Risk Factors
Psoriasis reflects genetic susceptibility and dysregulated immune pathways; it is not caused by contagion or poor cleanliness. A family history increases susceptibility but its absence does not exclude disease. Plaques can arise at sites of skin trauma, including friction, scratching, tattoos or surgery, a phenomenon often called the Koebner response. Streptococcal infection may precede a guttate eruption, particularly in younger people, but a sore throat history does not make every rash guttate psoriasis or justify antibiotics without evidence of bacterial infection.
Smoking, excess alcohol use, higher body weight and metabolic disease are clinically relevant because they can worsen general health, complicate treatment selection and coexist with more severe disease. They should prompt respectful support rather than withholding care or blaming the patient. Review medicines and timing: lithium, antimalarials, some beta-blockers and abrupt systemic corticosteroid exposure are reported aggravating factors, but causal attribution requires a temporal and clinical assessment. Never stop an essential medicine without discussion with the prescriber who manages the underlying condition.
Treatment risk is separate from disease risk. Large areas, damaged barrier, occlusion, prolonged uninterrupted use and high-potency topical corticosteroids increase the chance of local or systemic adverse effects. Before systemic immunomodulation, prior tuberculosis, household exposure, untreated infection, hepatitis status, HIV risk where clinically indicated, vaccination history, malignancy history, renal or hepatic disease, alcohol exposure, interacting medicines and pregnancy intentions materially affect the plan. In India, tuberculosis prevalence makes careful history and locally appropriate screening particularly important, but a positive screening test does not by itself diagnose active tuberculosis; symptoms and assessment for active disease remain essential.
Diagnosis
History
Ask when lesions began, their first site, rate of spread, itch, pain, bleeding, fissuring, sleep loss and relation to infection, trauma, new medicines or previous treatments. Clarify exactly which creams, tablets, injections, traditional remedies or combination products were used, including potency or active ingredient, frequency, duration, body site and response. Ask about family history; smoking and alcohol; diabetes, hypertension and dyslipidaemia care; mood; pregnancy plans; and access barriers. Ask specifically about prolonged morning stiffness, swollen digits, heel pain, inflammatory back pain, eye pain or photophobia, chronic diarrhoea and blood in stool.
Examination
Examine the whole skin, scalp, ears, umbilicus, natal cleft, palms, soles, nails and relevant mucosal or genital skin with consent and privacy. Describe morphology, distribution, scale, erythema or colour change, thickness, excoriation, fissuring, pustules and percentage body surface area without pretending that a single score captures burden. Look for nail pitting, onycholysis or subungual change, but consider fungal infection and trauma. Assess joints, digits and entheses when symptoms or signs suggest inflammatory arthritis. Record observations and systemic examination when the person is unwell, has widespread erythema, pustules or suspected infection.
Investigations
Typical stable plaque psoriasis is a clinical diagnosis and usually does not need blood tests or biopsy. Fungal microscopy or culture is appropriate when an annular, unilateral, atypical or steroid-modified eruption makes dermatophyte infection plausible. Biopsy is a specialist tool for diagnostic uncertainty, unusual evolution or concern for another inflammatory or neoplastic disorder; it is not a routine confirmation test. Baseline investigations are selected before a named systemic medicine according to its product information and local protocol, not ordered as a generic psoriasis panel. Suspected active infection, arthritis, eye disease or inflammatory bowel disease requires directed assessment and referral.
Differential Diagnosis
Tinea corporis often has an advancing active edge and central clearing, but topical corticosteroids can distort that pattern and create tinea incognito. Dermatophyte infection may coexist with psoriasis, especially in nails or folds, so apparent improvement after a steroid does not settle the diagnosis. Seborrhoeic dermatitis typically favours seborrhoeic areas with greasier scale; overlap on the scalp and face can occur. Atopic, irritant or allergic contact dermatitis is often itch-predominant and exposure patterned, but chronic plaques may become sharply demarcated and lichenified.
Pityriasis rosea, lichen planus, discoid lupus, secondary syphilis, drug eruption and pityriasis rubra pilaris have different distributions, morphology or systemic context. A new widespread scaly eruption after a medicine needs a medication review and attention to mucosal symptoms, blistering, skin pain and fever. Persistent solitary or unusual plaques, new disease in later life, nodules, ulceration, progressive erythroderma or failure of a well-delivered plausible plan should prompt reconsideration, including cutaneous T-cell lymphoma where appropriate.
Nail psoriasis can resemble onychomycosis, trauma and other inflammatory nail disease. Swollen painful joints may be psoriatic arthritis, rheumatoid arthritis, crystal disease, osteoarthritis, infection or another spondyloarthritis. Erythroderma can arise from psoriasis, eczema, drug reaction, lymphoma or other causes and requires urgent specialist assessment because temperature instability, fluid loss, infection and high-output cardiac strain are possible. Generalised pustules with systemic illness may represent generalised pustular psoriasis, drug-related acute generalised exanthematous pustulosis or infection. Do not diagnose a high-risk phenotype from a photograph alone.
Management
Start with shared goals: fewer symptomatic plaques, healed fissures, better sleep and function, lower treatment burden and safe access to review. Explain the relapsing course, reduce trauma and scratching, use bland moisturising care if acceptable, and address smoking, alcohol, weight, mood and cardiometabolic risk through ordinary primary-care pathways. Do not prescribe restrictive diets, antibiotics, antifungals or systemic corticosteroids merely because psoriasis is present. Ask openly about steroid-antifungal-antibacterial combinations, herbal products and over-the-counter fairness creams; unlabelled potent steroid exposure can cause atrophy, rebound disease and altered fungal infection.
For local stable plaques, select a topical vehicle that can actually be used: lotions, solutions or gels may suit hair-bearing skin; ointment may suit thick adherent scale; and creams may be acceptable for broader use. The treatment label should identify the active medicine, potency where relevant, site, frequency, maximum course, quantity, stop or step-down instruction and follow-up. Current guidelines recommends potency and formulation be matched to need, and emphasises that topical treatment alone may be inadequate when disease is extensive or has a major functional or psychological impact. Reassess diagnosis, adherence, application technique, contact allergy and infection before simply escalating strength.
Narrowband UVB can be offered by a capable dermatology phototherapy service when plaque or guttate psoriasis is not controlled with topical treatment alone. It needs controlled equipment, exposure documentation, eye and genital protection as indicated, review of photosensitising medicines and assessment of skin-cancer risk. It is not a home sunlight prescription and routine maintenance phototherapy is not recommended by current guidelines. Conventional systemic medicines, biologics and oral targeted medicines are considered when topical care is insufficient and disease is extensive, high-impact or phototherapy is ineffective, unsuitable or inaccessible. The specialist should define severity and impact, choose one agent rather than a shopping list, document safety screening, discuss pregnancy and contraception where relevant, and arrange monitoring and response review.
Pustular, erythrodermic or rapidly unstable psoriasis requires urgent dermatologist-led care. Admission may be required when there is systemic illness, dehydration, temperature disturbance, infection concern, extensive painful skin or inability to manage safely at home. Do not abruptly withdraw systemic corticosteroids or immunomodulatory drugs without the treating team; the immediate problem may be a complication, infection or a different diagnosis rather than ordinary loss of response.
Prescribing Information
Topical corticosteroids are not interchangeable percentage labels. Their clinical potency, vehicle and site matter. For face, flexures and genital psoriasis, current guidelines recommends only a short course of mild or moderate potency corticosteroid, once or twice daily for no more than two weeks, and warns that these sites are especially prone to atrophy. Potent and very potent corticosteroids should not be used at those sites. In adults, very potent topical corticosteroids should not be used continuously at any site beyond four weeks; potent topical corticosteroids should not be used continuously beyond eight weeks; and a four-week break is advised between courses of potent or very potent treatment. These are current guidelines recommendations, not a substitute for an Indian product label, paediatric formulary or individual examination.
A calcineurin inhibitor may be considered by a clinician with psoriasis expertise for an adult with face, flexural or genital disease when short-term moderate potency steroid treatment is inadequate or would create important local steroid risk. It is a specialist-led, site-specific decision; irritation, infection, product licensing and local availability matter. Vitamin D analogues, coal-tar preparations and keratolytic or scale-removal approaches can be part of a site-specific plan, but the exact product and schedule must follow the chosen formulation and local medicine information. Avoid vague directions such as “use as needed” for a potent steroid.
Phototherapy and systemic medicines are outside routine self-treatment. Before a conventional systemic medicine, biologic or targeted small molecule, the prescriber must review infection and tuberculosis risk, vaccinations, previous or active hepatitis as appropriate, blood counts and organ function when required by that medicine, concomitant medicines, malignancy history and reproductive plans. The exact tests, interval and contraindications differ by agent. In pregnancy, preconception, lactation, active infection or suspected tuberculosis, avoid copying a standard regimen: dermatologist and obstetric or relevant specialist input should select the lowest-risk effective approach. IADVL and EuroGuiDerm material supports medicine-specific screening, infection vigilance and reproductive counselling, but availability, indications and reimbursement must be verified in India.
When to Refer
Refer to dermatology when the diagnosis is uncertain, disease is extensive, plaques are resistant despite a documented topical plan, or high-impact sites such as the face, genital area, hands, feet, scalp or nails cause substantial distress or functional loss. Refer when phototherapy, conventional systemic treatment, biologic treatment or a targeted oral medicine is being considered. The referral should include morphology and distribution, severity and impact, photographs with consent where useful, prior topical active ingredients and durations, response and adverse effects, suspected triggers, infection and tuberculosis history, pregnancy plans, comorbidity, current medicines and access constraints.
Refer promptly to rheumatology or a combined dermatology-rheumatology pathway for persistent swollen joints, dactylitis, enthesitis, inflammatory-pattern back pain, functional decline or uncertainty about inflammatory arthritis. Eye pain, photophobia, reduced vision or a painful red eye needs same-day ophthalmology or emergency assessment, not routine dermatology follow-up. Persistent diarrhoea, rectal bleeding, weight loss or suspected inflammatory bowel disease warrants medical or gastroenterology assessment.
Urgent dermatology or hospital assessment is appropriate for erythroderma, widespread pustules, fever, rapidly worsening painful skin, systemic unwellness, suspected severe drug reaction or concern for sepsis. In Indian settings, the referral should identify the capability required: dermatology review, phototherapy, dermatopathology, rheumatology, obstetrics, infectious disease or inpatient skin-failure care. Confirm the receiving service and how the patient can obtain urgent help while waiting; “refer” without an accessible destination is not a safety plan.
Red Flags
Same-day assessment is required for near-generalised redness or scaling, fever, rigors, confusion, hypotension, reduced urine output, dehydration, severe pain, widespread pustules, rapidly spreading erosions, blistering or mucosal involvement. These features may indicate erythroderma, generalised pustular psoriasis, severe drug eruption, infection or another dangerous disorder. They are not safely managed by increasing a topical steroid at home. A person on systemic immunomodulation who develops fever, cough, dyspnoea, urinary symptoms, new focal infection or unexplained systemic illness needs prompt clinical review with the treating team’s advice.
Acute hot swollen joint, inability to bear weight, rapidly progressive monoarthritis or systemic sepsis features demand urgent assessment for septic arthritis or crystal disease; psoriasis does not protect against infection. A painful red photophobic eye, visual change or periocular vesicular eruption is an ophthalmic emergency. New chest pain, breathlessness, syncope, unilateral leg swelling or haemoptysis requires assessment for cardiopulmonary and thromboembolic causes rather than attribution to anxiety or a skin disease.
Treatment safety red flags include skin thinning, striae, bruising, telangiectasia or worsening after prolonged high-potency topical steroid; possible concealed steroid use; new jaundice, severe nausea, unusual bruising, major bleeding, pregnancy exposure concern or severe infection symptoms on systemic therapy. The response is not to independently stop every medicine, but to seek the prescriber’s urgent advice, bring all products or photographs of labels, and identify the exact exposure. Red flags override ordinary follow-up intervals.
Indian Clinical Context
Indian practice must separate broadly transferable evidence from local prescribing. current guidelines recommendations provide clear safety boundaries for topical potency, site and duration, but UK product licences, service pathways and formulary choices are not automatic Indian orders. Use currently licensed products, local institutional protocols and the exact product information available to the prescriber. Fixed-dose antifungal-antibacterial-steroid creams, potent steroid misuse and products with unclear ingredients are important practical risks. Ask without judgement, explain why a single diagnosis and a labelled treatment plan are safer, and avoid shaming people who sought affordable symptom relief.
Tuberculosis, hepatitis risk, crowded living, travel distance and out-of-pocket costs can materially affect systemic-treatment decisions. Screening and treatment of infection should be coordinated with local TB and infectious-disease services where indicated; neither a history alone nor a screening test alone confirms active disease. Phototherapy and biologic services are concentrated in larger centres, making adherence, transport, work absence, cold-chain arrangements where relevant and laboratory access part of the clinical decision. A lower-intensity but monitored plan may be safer than an idealised option that cannot be supplied or followed.
Recognise psoriasis in richly pigmented skin by texture, scale, thickness, itch, fissuring and the patient’s baseline rather than redness alone. Discuss cosmetic concerns and post-inflammatory pigment change without endorsing bleaching agents. The NMC curriculum supports clinical recognition, rational prescribing, counselling, safe referral and professional communication; it does not confer competence to initiate phototherapy, systemic immunosuppression or biologics without supervised specialist training. Document the person’s language, health-literacy and financial needs, then give written return precautions and a realistic follow-up point.
NMC Competency Mapping
The National Medical Commission CBME Curriculum 2024 provides the Indian curricular frame for recognising common dermatological disease, taking a relevant history, examining skin and appendages, selecting appropriate initial management, counselling and referring when complexity or danger exceeds the setting. For psoriasis, an undergraduate learner should recognise common plaque, scalp, nail and flexural patterns; elicit symptoms, treatment exposure, impact, arthritis symptoms and infection risk; and distinguish a stable plaque presentation from a potentially unstable pustular or erythrodermic illness.
The learner should demonstrate safe topical prescribing habits: identify the preparation and potency, account for thin-skin and occluded sites, document duration, counsel about application and adverse effects, and review response rather than escalating blindly. They should not confuse percentage strength with potency across unrelated products. They should be able to explain why unlabelled combination creams and intermittent unsupervised potent steroid use are unsafe, while also avoiding steroid phobia and undertreatment.
Competence includes recognising the need for dermatology input for phototherapy or systemic treatment, rheumatology input for suspected psoriatic arthritis, ophthalmology input for a painful photophobic eye and emergency care for erythroderma, systemic illness or widespread pustules. Learners should understand the broad purpose of tuberculosis, hepatitis, vaccination, laboratory and reproductive-risk review before specialist immunomodulatory therapy, but must not independently invent a screening panel or regimen. Assessment should reward sound clinical reasoning, documentation, communication and escalation rather than memorising a biologic sequence.
Key Exam Pearls for NEET PG
Psoriasis is a clinical diagnosis, but a scaly plaque is not automatically psoriasis. Tinea can be steroid-modified; nail disease can be fungal; and a new widespread eruption can be drug-related. Always identify the morphology, distribution and systemic context before selecting treatment. High-impact disease may be severe despite limited body surface area, especially on hands, feet, scalp, nails or genital skin. Ask about dactylitis, enthesitis and inflammatory back pain rather than waiting for the patient to label symptoms as arthritis.
Potency and site are exam-relevant safety facts. Face, flexures and genital skin require short-term mild or moderate potency topical corticosteroid only; potent and very potent topical corticosteroids should not be used there. current guidelines sets maximum continuous courses and breaks for stronger preparations, but an examination answer should still state that the exact prescription depends on the named product, age and local formulary. Repeated, vague high-potency topical steroid use is not rational management.
Narrowband UVB is a supervised escalation for plaque or guttate disease not controlled with topical care. Systemic medicines and biologics require a specialist assessment of phenotype, infection risk including tuberculosis, vaccination and reproductive considerations. Erythroderma, generalised pustules, fever, painful skin or systemic illness are urgent presentations. The safest answer to pregnancy, active infection, renal or hepatic disease, or a possible biologic adverse event is individualised specialist management, not a memorised drug regimen.
Frequently Asked Questions
Is psoriasis contagious or caused by poor hygiene?
No. Psoriasis is an immune-mediated inflammatory condition and cannot be passed by skin contact, shared clothing or household proximity. Good skin care can reduce irritation and improve comfort, but it does not prove that cleanliness caused or cures the disease. Stigma can be a major harm, so clinicians should state this plainly and ask about work, school, family and relationship effects.
Can a potent steroid cream be used on facial psoriasis?
Not as a routine shortcut. Facial, flexural and genital skin is particularly vulnerable to corticosteroid atrophy. Current guidelines recommends a short course of mild or moderate potency corticosteroid at these sites and advises against potent or very potent corticosteroids there. The clinician should name the exact product, site, duration and review plan; persistent disease may need dermatology-led steroid-sparing treatment or diagnostic reconsideration.
When should psoriasis prompt concern for psoriatic arthritis?
Persistent swollen joints, a whole swollen digit, heel pain, inflammatory-pattern back pain, prolonged morning stiffness or declining function should prompt assessment and referral. Psoriatic arthritis can occur with little visible skin disease and is not diagnosed by one blood test. A hot acutely swollen joint or fever requires urgent assessment for infection or crystal arthritis rather than routine outpatient labelling.
Are phototherapy and biologics appropriate in pregnancy or after tuberculosis exposure?
They can never be chosen from a generic online list. Pregnancy, breastfeeding, active or past tuberculosis, hepatitis risk, vaccination status and the exact medicine materially alter benefit-risk assessment. A dermatology specialist should coordinate with obstetric, TB or infectious-disease services as required. Do not abruptly stop an established systemic medicine without urgent prescriber advice, but do report infection symptoms or a pregnancy concern promptly.
Inside MedNext for this topic
- 411 MedNext-authored chapters
- 80,000+ MCQ bank
- 15 study modes
- a growing library of visual revision sheets
Study modes
- Notes
- MCQ
- Audio
- Video
- Visual
- 3D Anatomy
- Trace
- Flashcards
- Mnemonics
- Image Bank
- Clinical
- Microscopy
- Audio QBank
- Cadaver
- Book Match
Continue reading
Clinical GuidesAll Clinical Guides
Browse all clinical management guides for Indian medical practice.
Test your knowledge
Attempt structured MCQs on this topic to consolidate your understanding and connect the guide to exam-focused practice.
Try MCQs on this topic